AAME vs PLAB

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 02, 2026

AAME

42.2
AI Score
VS
PLAB Wins

PLAB

51.8
AI Score

Investment Advisor Scores

AAME

42score
Recommendation
HOLD

PLAB

52score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric AAME PLAB Winner
Revenue 159.18M 435.01M PLAB
Net Income 4.70M 74.37M PLAB
Net Margin 2.9% 17.1% PLAB
ROE 4.3% 6.0% PLAB
ROA 1.1% 3.9% PLAB
Total Assets 430.86M 1.93B PLAB
Cash 34.44M 511.49M PLAB
Free Cash Flow 14.73M 50.85M PLAB

Relative Price Performance (Last 90 Days)

AAME 1M: -8.2% · 3M: -39.1% PLAB 1M: +8.7% · 3M: -37.5%

Current Technical Phase

AAME

Markdown
Sell / avoid

Price below a falling SMA50 (slope -16.1%), weak momentum, RSI 40

RSI (14): 40.1 · Price: $1.57

PLAB

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 52

RSI (14): 52.4 · Price: $31.36

Fundamentals Snapshot

Metric AAME PLAB
Market Cap
Forward P/E 7.4 15.5
Trailing P/E 6.7 11.2
Revenue (TTM)
Revenue Growth 0.2% 0.0%
Gross Margin 0.1% 0.3%
Operating Margin 0.0% 0.2%
EPS 0.23 2.71
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, PLAB is currently the stronger investment candidate, winning 8 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.